PLUS THERAPEUTICS, INC. financial data

Symbol
PSTV on Nasdaq
Location
Austin, TX
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 91.3 % +64.9%
Debt-to-equity -295 % -3.26%
Return On Equity 336 % +23.7%
Return On Assets -173 % -17.8%
Operating Margin -256 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 137M shares +2231%
Common Stock, Shares, Outstanding 132M shares +2132%
Entity Public Float 8.2M USD +41.4%
Common Stock, Value, Issued 132K USD +2100%
Weighted Average Number of Shares Outstanding, Basic 107M shares +1268%
Weighted Average Number of Shares Outstanding, Diluted 107M shares +1268%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.26M USD -4.05%
Research and Development Expense 7.62M USD -31.9%
General and Administrative Expense 11.1M USD +20.7%
Operating Income (Loss) -13.5M USD +8.17%
Nonoperating Income (Expense) -7.12M USD -503%
Net Income (Loss) Attributable to Parent -20.6M USD -59.7%
Earnings Per Share, Basic -1 USD/shares +26%
Earnings Per Share, Diluted -1 USD/shares +27.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.3M USD +987%
Other Assets, Current 985K USD +71%
Assets, Current 17.6M USD +228%
Property, Plant and Equipment, Net 273K USD -53.8%
Operating Lease, Right-of-Use Asset 20K USD -81.1%
Goodwill 372K USD 0%
Other Assets, Noncurrent 45K USD +40.6%
Assets 18.7M USD +168%
Accounts Payable, Current 9.47M USD +99.1%
Liabilities, Current 13.6M USD +12.4%
Operating Lease, Liability, Noncurrent 31K USD -63.5%
Liabilities 13.6M USD +12%
Retained Earnings (Accumulated Deficit) -510M USD -4.2%
Stockholders' Equity Attributable to Parent 5.05M USD
Liabilities and Equity 18.7M USD +168%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.17M USD -36.8%
Net Cash Provided by (Used in) Financing Activities 12.4M USD
Net Cash Provided by (Used in) Investing Activities 3.56M USD
Common Stock, Shares Authorized 2B shares +1900%
Common Stock, Shares, Issued 132M shares +2042%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.79M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 23K USD -68.5%
Deferred Tax Assets, Valuation Allowance 22.6M USD +15.9%
Deferred Tax Assets, Gross 22.6M USD +15.7%
Operating Lease, Liability 75K USD -63.4%
Payments to Acquire Property, Plant, and Equipment 3K USD -92.5%
Lessee, Operating Lease, Liability, to be Paid 80K USD -63.1%
Property, Plant and Equipment, Gross 3.59M USD +4.24%
Operating Lease, Liability, Current 21K USD -69.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11K USD -81.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 69K USD -52.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +9.37%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5K USD -58.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11K USD -38.9%
Deferred Tax Assets, Operating Loss Carryforwards 15.4M USD +15%
Preferred Stock, Shares Issued 1.95K shares 0%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 424K USD +3.92%
Operating Lease, Payments 148K USD -26.7%
Additional Paid in Capital 516M USD +6.33%
Preferred Stock, Shares Outstanding 1.95K shares 0%
Depreciation, Depletion and Amortization 146K USD -5.81%
Deferred Tax Assets, Net of Valuation Allowance 15K USD -65.1%
Interest Expense 210K USD -63.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%